Argentum Medical's Silverlon Antimicrobial Dressings Demonstrate Kill Rate of P. Acnes of Greater than 99.999% Reduction in 3 Hours
Silverlon is now shown to combat Propionibacterium acnes, one of the most common skin pathogens that can cause clinical conditions, affecting more than 45 million individuals in the United States
GENEVA, Ill., Aug. 20, 2019 /PRNewswire-PRWeb/ -- Recent lab studies have demonstrated that Silverlon® antimicrobial dressings can effectively kill Propionibacterium acnes (P. Acnes), a gram-positive human skin pathogen involved in the pathogenesis of acne. It is estimated that nearly 20 percent of all visits to dermatologists are related to the treatment of acne and it is suspected to be involved in post-operative infections, prostheses failures in shoulder surgeries, and most recently an inflammation of lumbar nerve roots leading to sciatica.
Argentum Medical, pioneers in the use of silver-plated technology and makers of Silverlon, commissioned Microbiological Consultants, an independent FDA-registered pharmaceutical testing laboratory, to establish if the silver ions in their dressings would be able to kill P. Acnes bacteria. Lab findings have proven a greater than 6 log reduction after just three hours of exposure.
"Silverlon starts working immediately to generate silver ions and has been tested against multiple pathogens, such as Candida Auris and MRSA," states Amanda Budak, PhD, RN clinical director of Argentum Medical. "We are proud to expand this pathogen list to now include P. Acnes."
P. Acnes has emerged as a major pathogen responsible for postoperative shoulder infections after both arthroscopy and arthroplasty procedures. Management of infections can include debridement, revisions, and intravenous antibiotics.
About Argentum Medical
Argentum Medical pioneered the use of silver-plated nylon. Specializing in the development of innovative products made from silver-plated nylon, the company continues to explore new applications and markets for its Silverlon® technology in keeping with its corporate mission to improve clinical outcomes.
About Silverlon
As an evidence-based antimicrobial dressing, Silverlon products contain 50 to 100 times more metallic silver ions than other silver-impregnated dressings. Silverlon® wound dressings have a permanently plated metallic surface, which provides the antimicrobial benefits of silver in the dressing without staining the skin and without increasing bioburden.
Originally developed for the U.S. military, Silverlon is still extensively used for the management of burn and blast injuries. Studies have shown Silverlon to be highly effective in hostile and austere military environments. In 2019, Silverlon received 510(k) clearance from the Food and Drug Administration (FDA) for Vapor Sulfur Mustard indication for its Silverlon Burn and Wound Care products. This is the first medical product cleared in the U.S. for use on these injuries. Silverlon dressings also are used by surgeons and other healthcare professionals around the world on surgical wounds, in negative pressure wound therapy, on chronic wounds, burns, skin grafts, and IV and catheter-related wounds.
For more information, visit http://www.silverlon.com.
SOURCE Silverlon
Share this article